Joint

Joint EV/EBITDA

The EV/EBITDA (Enterprise Value to EBITDA) of Joint (JYNT) as of Nov 21, 2026 is 126.87. In the previous year, EV/EBITDA (Enterprise Value to EBITDA) was -175.91 — a change of -172.12% (higher).

EV/EBITDA

126.87

YoY

-172.12%

Last updated:

EV/EBITDA (Enterprise Value to EBITDA) of Joint is 2025 126.87 . EV/EBITDA (Enterprise Value to EBITDA) of Joint was 2024 -175.91 . It decreases by -172.12% higher compared to the previous year.

The Joint EV/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBITDA
Date
EV/EBITDA
Jan 1, 2018
59.66 USD
Jan 1, 2019
22.79 USD
Jan 1, 2020
13.82 USD
Jan 1, 2021
11.91 USD
Jan 1, 2022
17.72 USD
Jan 1, 2023
62.65 USD
Jan 1, 2024
-175.91 USD
Jan 1, 2025
126.87 USD
The Joint EV/EBITDA history
YEAREV/EBITDAYoY
126.87-172.12%
-175.91-380.77%
62.65+253.59%
17.72+48.78%
11.91-13.84%
13.82-39.35%
22.79-61.80%
59.66-162.48%
-95.50+953.24%
-9.07-26.66%
-12.36-81.48%
-66.75—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Joint Stock analysis

What does Joint do? The Joint Corp is an American company specializing in providing medical and wellness services. It was founded in 2010 and is headquartered in Scottsdale, Arizona. The company currently operates over 600 clinics in the United States and is listed on NASDAQ under the ticker symbol JYNT. Its business model focuses on treating patients with joint and muscle pain through a chain of clinics that specialize in chiropractic, physical therapy, and other wellness-based treatments. The company's main strategy for expansion is through franchise systems, providing support to franchisees in areas such as location selection, building lease, and financing. Joint clinics offer a range of products and services, including chiropractic treatments, physical therapy, sports medicine, acupuncture, supplements, and pain medication. The company has recently partnered with a franchise company in Canada to open clinics in multiple Canadian cities and plans to open clinics in other countries in the coming years. While The Joint brand is known for its affordable wellness concept, it has faced mixed reception from the chiropractic industry due to concerns about quality and patient safety. However, the company has taken steps to address these concerns by hiring qualified chiropractors and physicians and implementing strict quality controls. Overall, The Joint Corp is focused on becoming a leading wellness company in the USA and worldwide, aiming to expand and offer innovative ways to improve patient well-being. Joint is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Joint stock

EV/EBITDA (Enterprise Value to EBITDA) of Joint is 126.87 in 2025.

EV/EBITDA (Enterprise Value to EBITDA) of Joint changed from -175.91 to 126.87, representing a -172.12% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/EBITDA (Enterprise Value to EBITDA) Joint since 2006 – with annual values, charts, and detailed analysis.

The EV/EBITDA ratio is a widely used valuation metric that compares a company's enterprise value to its EBITDA. It normalizes for differences in capital structure, taxation, and depreciation policies.

To evaluate EV/EBITDA (Enterprise Value to EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBITDA (Enterprise Value to EBITDA).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBITDA (Enterprise Value to EBITDA)'s Joint with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Joint

All Key Metrics — Joint